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Abstract: Innate lymphoid cells (ILC) are important players of early immune defenses in situations
like lymphoid organogenesis or in case of immune response to inflammation, infection and cancer.
Th1 and Th2 antagonism is crucial for the regulation of immune responses, however mechanisms
are still unclear for ILC functions. ILC2 and NK cells were reported to be both involved in allergic
airway diseases and were shown to be able to interplay in the regulation of the immune response.
CXCR6 is a common chemokine receptor expressed by all ILC, and its deficiency affects ILC2 and
ILC1/NK cell numbers and functions in lungs in both steady-state and inflammatory conditions.
We determined that the absence of a specific ILC2 KLRG1+ST2− subset in CXCR6-deficient mice is
probably dependent on CXCR6 for its recruitment to the lung under inflammation. We show that
despite their decreased numbers, lung CXCR6-deficient ILC2 are even more activated cells producing
large amount of type 2 cytokines that could drive eosinophilia. This is strongly associated to the
decrease of the lung Th1 response in CXCR6-deficient mice.
Keywords: Immunology; ILC immunity; CXCR6; Lung inflammation
1. Introduction
Innate lymphoid cells (ILC) are lymphocytes that do not express rearranged antigen receptors such
as T and B cells. They have been recently classified into five subsets (NK cells, ILC1, ILC2, ILC3 and
LTi cells) based on new data for their development and functions [1]. Members of the ILC family are
functionally distinct, with Th cell subset classification similarities such as regulation by soluble factors
and specific transcriptional factor profile. Mostly considered as tissue-resident cells, they contribute to
the maintenance of tissue homeostasis and the containment of commensals by cytokine production at
mucosal barriers. They are also critical during immune responses to pathogens with a concomitant
action on tissue inflammation.
NK cells and ILC1 are both Tbet-dependent innate lymphocytes that produce IFNγ whereas ILC2
includes RORα/GATA3-dependent cells that produce type Th2 cytokines. Lung ILC2 play a crucial
role in promoting allergic airway inflammation during innate immune responses [2,3], whereas lung
NK cells could regulate the early type 2 immune response by an IFNγ retro-control [4]. By the release
of IL-5 and IL-13, ILC2 in the lungs respectively mediates eosinophilia and goblet cell activation for
the production of mucus [5,6]. Intranasal administration of the protease allergen papain induces the
release of type 2 activating cytokines by lung epithelial cells and macrophages to activate ILC2 [7].
Lung explants after papain induction were shown to produce alarmins (IL-25, IL-33) and thymic
stromal lymphopoietin (TSLP); all of them can stimulate ILC2 to participate in lung inflammation
Int. J. Mol. Sci. 2019, 20, 5493; doi:10.3390/ijms20215493 www.mdpi.com/journal/ijms
Int. J. Mol. Sci. 2019, 20, 5493 2 of 17
by secreting Th2 cytokines [7,8]. NK cell functions during lung allergy are not so well understood
as studies using different models of lung allergy have been quite contradictory. NK cells can induce
the development of asthma in allergen-challenged RAG−/− mice and appear essential for allergic
sensitization [9]. On the contrary, NK cells can protect from OVA-induced asthma by contributing to
the resolution of allergic lung inflammation in mice. Indeed, they were shown as potent cytotoxic cells
against eosinophils and specific CD4+ T cells [10]. Lung NK cells can limit viral- and allergen-specific
lung type 2 responses through the release of IFNγ [11]. Moreover, in the early stage of papain-induced
inflammation, if NK are depleted, the lung inflammation is increased by the enhancement of the ILC2
response [4]. Finally, activated NK cells could restrain the inflammatory effector cells in asthmatic
patients [12]. Alternatively, models of contact hypersensitivity have suggested that ILC2 are potent
Th1 negative regulators for type 1 immune responses [13].
The bronchial epithelia constitutively express CXCL16, suggesting a role for CXCR6 in lymphocyte
homing, recruitment and retention. We have previously shown that ILC precursors both in the adult
bone marrow and fetal liver express CXCR6 [14]. We already demonstrated that CXCR6 participates in
the retention of ILC precursors into the bone marrow in homeostatic conditions [15]. Most ILC of the
intestinal tract express CXCR6 and its deficiency from the ILC3 intestinal subsets perturbs the intestinal
ILC homeostasis [16,17]. Homing and cell trafficking use a specific combination of adhesion molecules
and chemokine receptors. CXCR6 expression could be correlated to differential homing and/or function
of ILC subsets. CXCR6+ NK cells have been defined as persistent memory hepatic cells [18]. Most of
lung NK cells are circulating, and lineage tracing studies are still needed to confirm the existence of a
small percentage of tissue-resident ILC1 in the lungs [19]. In lungs, NK cells have been defined as
hypofunctional probably due to their function in maintaining the pulmonary homeostasis [20].
In this study, we took advantage of a mouse model bearing targeted insertion of GFP reporter
into the CXCR6 locus (CXCR6+/GFP mice) to follow CXCR6+ ILC subsets during lung inflammation.
Moreover, it also allowed to inspect the effect of CXCR6 loss on ILC subset functions in lung under
steady-state and inflammatory conditions. Competitive reconstitutions demonstrated that for both
ILC2 and NK/ILC1, CXCR6 has an intrinsic role on their homing to the lung in steady-state. We used
intranasal papain challenges to study ILC2 response and the global type 2 response in absence of
CXCR6 expression. We show here that CXCR6 is expressed by a majority of lung ILC2 at homeostasis
and that its loss results in a decrease of ILC2 numbers and an exacerbation of the ILC2 activated
phenotype. CXCR6 is also present at the surface of ILC1/NK subsets and is important for the ILC1
homing to the lung and IFNγ secretive capacities. While pulmonary ILC2 are reduced in numbers,
their capacity to release IL-5/IL-13 is kept by the activated residual subset of ILC2. Finally, in case of
lung inflammation, CXCR6 deficiency allowed us to determine that CXCR6 is not crucial to maintain
type 2 immune responses. In absence of CXCR6, the increased secretive ILC2 capacities could be
related to the decreased capacities of ILC1 to secrete IFNγ. Hence, we suggest that the CXCR6/CXCL16
axis in the lung is mostly related to ILC homing and to Th1 lineage functions as restricting the type
2 response.
2. Results
2.1. Lung ILC Subsets Differentially Express CXCR6
We examined the proportion of lung ILC subsets that express the chemokine receptor CXCR6
in homeostatic conditions using Rag2−/− CXCR6 reporter mice (Rag2−/− CXCR6+/GFP). All our lung
preparations were done using an exsanguination protocol that efficiently removed most circulating
ILC2, as shown in Figure S1, using control intravital injections of i.v. CD45 antibody before the sacrifice
of the mice (Figure S1). The figure proves that exsanguination eliminated most of the circulating
ILC2 with only 4% of intravascular ILC2 remaining. On the contrary, NK cells that are known to be
all intravascularly positioned remained after exsanguination with a clear positive i.v. CD45 staining
suggesting they are actively maintained in this area and not circulating cells.
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ILC2 are enriched among lineage-negative lung leukocytes (CD45+Lin−Nkp46−NK1.1−).
Depending on the expression of KLRG1 and Sca1 markers, three main populations could be separated
into KLRG1−Sca1−, KLRG1+Sca1+ and KLRG1−Sca1+ subsets. These subsets were studied for the
expression of CXCR6 or GATA3 (Figure 1A). Cells enriched in NK/ILC1 subsets were gated as
CD45+LinNkp46+NK1.1+ cells and could serve as a negative control for GATA3 expression (Figure 1A).
Considering the positive levels of GATA3 expression, we showed that the KLRG1+Sca1+ subset
was largely constituted of ILC2 whereas the KLRG1−Sca1− subset was mostly devoid of them. The
KLRG1−Sca1+ subset was enriched in ILC2 cells. We showed that most lung ILC2 are CXCR6-expressing
cells as 85% of the KLRG1+Sca1+ cells were CXCR6+, like 44% of the KLRG1−Sca1+ subset (Figure 1A).
Identical experiments were performed on CXCR6 reporter mice with a wild-type (WT) background
(CXCR6+/GFP) (Figure S2). The ILC2 KLRG1+ subset was mostly CXCR6+ in both Rag and WT
background (74% and 85%, respectively) whereas the ILC2 KLRG1− subset was less prone to express
CXCR6 in a WT background (13% compared to 44% in Rag).
Figure 1. CXCR6 is expressed by lung ILCs. (A) Flow cytometry analyses of CD45+ Lin− (CD3,
CD5, CD19, TCRβ, TCRγδ, Gr1, Ter119, CD8α and F4/80) NKp46− NK1.1− lung cells from Rag−/−
CXCR6+/GFP mice. Different subsets are distinguished depending on the expression of KLRG1, Sca1 and
GATA3 (GATA3 negative control was performed on CD45+ Lin− NK1.1+ NKp46+ cells). Sca1 and
CXCR6 expression from KLRG1+ and KLRG1− populations (graphs are representative of n = 6).
(B) Flow cytometry analyses of CD45+ Lin− lung cells from Rag−/− CXCR6+/GFP mice. CD127 and
CXCR6 expression among ILC1/NK (NK1.1+ NKp46+) cells (graphs are representative of n = 6).
NK cells and ILC1-like cells were selected as CD45+Lin−Nkp46+NK1.1+ cells and represent
one of the most abundant lymphoid populations of the lung. CXCR6 expression was restricted to
a small proportion of these cells (Figure 1B). If we consider that ILC1 exist in the lungs and could
be distinguished from NK cells on the basis of the CD127 expression, we determined that NK cells
are the most frequent lymphocytes among the lung Nkp46+NK1.1+ cells. Using this discriminant
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marker, we showed that CXCR6 was expressed by nearly half of the lung ILC1. On the contrary,
only 4–5% of lung NK cells are CXCR6+ cells (Figure 1B). The pulmonary NK/ILC1 population still
poorly expressed CXCR6 in a WT background with only 8% of the cells being CXCR6+ (Figure S2).
In conclusion, in homeostatic conditions CXCR6 was expressed by almost all lung KLRG1+ ILC2 while
it only marked a small population of lung NK/ILC1. However, it is unknown whether CXCR6 is
required for maintenance of ILC homeostasis in the lung in steady state and after inflammation.
2.2. CXCR6 Deficiency Alters Lung ILC Subset Distribution at Homeostasis
In steady state conditions, the absolute numbers of blood circulating cNK and ILC2 were not
significantly modified by CXCR6 deficiency (Figure 2A, left graph). CXCR6-deficient (CXCR6GFP/GFP)
and -sufficient (CXCR6+/GFP) mice were both on the Rag-deficient background. Due to the absence
of any T cell contaminants, ILC2 were more easily detected and more frequent. Hence, as already
described for ILC2 from Rag-deficient mice, their total numbers in tissues and circulation were increased
compared to ILC2 numbers from wild-type mice [21,22]. The digestive tracts of CXCR6-deficient and
-sufficient mice were also analyzed for ILC subset respective numbers. As already shown [15,17],
ILC3 from the intestinal lamina propria (LP) were decreased in numbers in case of CXCR6 deficiency.
Identically, cNK, ILC1, ILC2 and ILC3 subsets from the mesenteric lymph node (mLN) were also
decreased in numbers after CXCR6 deletion. Indeed, cNK cells and ILC2 from mLN were decreased by
half in CXCR6GFP/GFP mice (Figure 2A, right graph). In lung, the deletion of CXCR6 also reduced ILC
absolute numbers by a factor of 3 for ILC2 (Lin−CD45+NK1.1−Sca1+) and by a factor of 4 for the type 1
innate lymphocytes (NK/ILC1: Lin−CD45+NKp46+NK11+) (Figure 2B).
To have a better understanding of the CXCR6 role for lung ILC, we performed competitive
reconstitution experiments by injecting a mix of wild-type (WT) and CXCR6-deficient hematopoietic
stem cells (HSCs) (Figure 2C). Sub-lethal irradiated recipient Rag2−/− γc−/− CD45.1 mice were
reconstituted with a mix of equal numbers of donor bone marrow-derived Lin−Sca1+cKit+ cells
(LSK) from WT CD45.1 mice and CXCR6-sufficient (CD45.2+CXCR6+/GFP) or CXCR6-deficient
(CD45.2+CXCR6GFP/GFP) mice (Figure 2C). When WT LSK compete with CXCR6-deficient LSK
to reconstitute ILC2 and cNK/ILC1 lung populations, lymphoid progenitors from WT origin are
significantly favored (Figure 2C,D). No difference was observed in the LSK compartment reconstitution
capacities consistent with the absence of CXCR6 expression by LSK. BM CXCR6 expression starts only
at the α-lymphoid stage [15]. It indicates that CXCR6 deficiency acts as a cell-intrinsic disadvantage for
innate lymphocyte homing to the lungs. Since reconstitution with CXCR6-deficient progenitors is less
efficient, we determined here that CXCR6 is important for normal adult NK/ILC1 and ILC2 specific
subsets to home to the steady-state lungs (Figure 2D). We cannot clearly determine the cause of this
lung homing decrease. It could be due to default of ILC2 recruitment to the lung in absence of CXCR6
or to an upstream default of ILC progenitor maturation in the bone marrow.
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Figure 2. Diverse effects of CXCR6 deficiency on ILC tissue distribution. (A) Absolute numbers
of different ILC subsets in CD45+ Lin− (CD3, CD5, CD19, TCRβ, TCRγδ, Gr1, Ter119, CD8α and
F4/80) blood / Lamina Propria (LP) / mesenteric Lymph Node (mLN) cells from Rag−/− CXCR6+/GFP
and Rag−/− CXCR6GFP/GFP mice. (+/GFP = 7, GFP/GFP = 7) (B) Absolute number of ILC2 (CD45+
Lin− NK1.1− Sca1+) and ILC1/NK (CD45+ Lin− NK1.1+ NKp46+) lung cells from Rag−/− CXCR6+/GFP
and Rag−/− CXCR6GFP/GFP mice. (+/GFP = 6, GFP/GFP = 4) (C) Protocol of competitive experiment,
5000 LSK cells from CD45.1 C57Bl/6J mice and 5000 LSK cells from CD45.2 Rag−/− CXCR6+/GFP or
Rag−/− CXCR6GFP/GFP mice were injected in irradiated (400 rad) Rag−/− γc−/− CD45.1. (D) Repartition of
CD45.1 and CD45.2 CXCR6+/GFP or CXCR6GFP/GFP reconstituted cells in ILC1/NK and ILC2. (+/GFP = 4,
GFP/GFP = 4) (* p < 0.05 or ** p < 0.01)
2.3. In Case of Lung Inflammation, CXCR6 Deficiency Impacts the Number of ILC2 and Their Phenotype
We used intranasal papain protease challenges in order to stimulate a strong allergen airway
inflammation [7]. After intranasal papain administration, we observed that the activated ILC2
phenotype was exacerbated in case of CXCR6 deficiency (Figure 3). ILC2 from CXCR6-deficient lungs
have increased levels of ST2 expression (Figure 3A,B).
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Figure 3. CXCR6 deficiency modifies the phenotype and frequency of ILC2 in an inflammatory context
(papain stimulation) (A) Flow cytometry analysis of CD45+ Lin− (CD3, CD5, CD19, TCRβ, TCRγδ,
Gr1, Ter119, CD8α and F4/80) lung cells from Rag−/− CXCR6+/GFP and Rag−/− CXCR6GFP/GFP mice.
Different populations of ILC2 are obtained depending on the ST2 and GATA3 expression. (+/GFP = 13,
GFP/GFP = 11) (B) ST2 MFI of GATA3+ lung cells from Rag−/− CXCR6+/GFP and Rag−/− CXCR6GFP/GFP
mice. (+/+ = 5, +/GFP = 13, GFP/GFP = 11) (C) Frequency and absolute number of lung ILC2 (CD45+
Lin− GATA3+) from Rag−/− CXCR6+/+ and Rag−/− CXCR6+/GFP (Ctrl), and Rag−/− CXCR6GFP/GFP mice.
(Ctrl = 18, GFP/GFP = 11) (D) Frequency and absolute number of lung ST2− ILC2 and ST2+ ILC2 (CD45+
Lin− GATA3+) from Rag−/− CXCR6+/+ and Rag−/− CXCR6+/GFP (Ctrl), and Rag−/− CXCR6GFP/GFP mice.
(Ctrl = 18, GFP/GFP = 11) (E) Flow cytometry analyses of lungST2+ ILC2 (CD45+ CD3−, NK1.1−,
Sca1+, CD127+) and lung ST2− ILC2 (CD45+ CD3−, NK1.1−, Sca1+, CD127+) from C57Bl6/J mice
for Amphiregulin (Areg) secretion. (n = 4) (F) KLRG1 MFI of GATA3+ ST2+ lung cells from Rag−/−
CXCR6+/GFP and Rag−/− CXCR6GFP/GFP mice. (+/GFP = 6, GFP/GFP = 4) (G) KLRG1+ and KLRG1−
repartition in GATA3+ ST2+ lung cells from Rag−/− CXCR6+/GFP and Rag−/− CXCR6GFP/GFP mice.
(+/GFP = 6, GFP/GFP = 4) (H) Frequency and absolute number of KLRG1+ ST2+ and KLRG1− ST2+ lung
ILC2 (CD45+ Lin− GATA3+) from Rag−/− CXCR6+/GFP and Rag−/− CXCR6GFP/GFP mice. (+/GFP = 6,
GFP/GFP = 4) (** p < 0.01 or **** p < 0.001).
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The frequency of lung ILC2 was significantly decreased in CXCR6GFP/GFP mice compared to their
CXCR6-sufficient counterparts (Figure 3C, left panel). According to the decrease of their frequency,
pulmonary ILC2 were also significantly less numerous in case of CXCR6 deficiency (Figure 3C, right
panel), confirming a clear decrease of ILC2 numbers present in inflammatory lungs. In the lung,
the inflammatory subset of ILC2 (iILC2) has been described as constituted of ST2− KLRG1+ cells
in the vascular area and is different from ST2+ KLRG1− ILC2 that are defined as the tissue resident
subset [23,24]. In CXCR6-deficient lungs, both iILC2 (ST2− ILC2) and nILC2 (ST2+ ILC2) subsets
were reduced in frequency and numbers even if the strongest effect was observed for iILC2 that were
reduced by a factor of 6 (Figure 3D). By comparing ST2+ and ST2− subsets’ capacities for secreting the
amphiregulin (Areg) in papain-inflamed WT lungs, we found that ST2− ILC2 secreted higher levels of
Areg (Figure 3E). Since the ST2− subset was strongly decreased in CXCR6-deficient lungs, we suggest
that the wound healing capacities of CXCR6-deficient ILC2 could be questioned (Figure 3E).
Surprisingly, KLRG1 expression was largely increased among nILC2 in CXCR6-deficient lungs and
a new KLRG1hi ST2hi subset of ILC2 was defined (Figure 3F). The distribution of these activated nILC2
in the lung was significantly biased in CXCR6-deficient lungs, with 64% of ST2+ nILC2 being KLRG1hi
compared to 24% in CXCR6-sufficient lungs after papain challenges (Figure 3G). Finally, we determined
that in absence of CXCR6, the decrease among nILC2 was due to the specific loss of the KLRG1− subset.
The ST2+ KLRG1+ counterpart was maintained in normal ratio during pulmonary inflammation
despite higher levels of ST2 and KLRG1 surface expression (Figure 3H). Identical experiments were
performed on CXCR6-deficient mice in a WT background (Figure S3). Globally, the absence of CXCR6
in mice with T and B cells had similar issues with a decrease of lung ILC2 numbers by all subsets
(KLRG1+, KLRG1−, ST2+ and ST2−) after papain challenges. Moreover, iILC2 still expressed higher
levels of KLRG1 in CXCR6-deficient conditions (Figure S3).
2.4. CXCR6 Does Not Influence the Capacity of ILC2 to Secrete IL-5 and IL-13 during Inflammation
In order to follow the repercussion of CXCR6 deficiency on ILC2 secretive abilities, we followed
IL-5 and IL-13 type 2 immune response after papain lung inflammation (Figure 4). As expected, lung
ILC2 subsets were either able to secrete IL-5 alone or combined IL-5/IL-13 after intranasal papain
administration (Figure 4A). CXCR6 deficiency did not affect the distribution of these secretive subsets
(Figure 4A). Indeed, we measured equal amounts of IL-5 and IL-13 cytokines in the bronchoalveolar
lavages (BAL) of CXCR6-sufficient and -deficient mice (Figure 4B). Then, we checked for the resulting
levels of eosinophilia in both lungs and BAL. The eosinophil recruitment was similar in CXCR6-sufficient
and -deficient mice in coherence with the levels of IL-5/IL-13 (Figure 4C). We demonstrated that after
papain stimulation a typical type 2 immune response was mounted in CXCR6-deficient mice. We then
decided to look for lung ILC2 expression of other type 2 cytokines such as IL-4 and IL-9 from all
genotypes (CXCR6+/+, CXCR6+/GFP, CXCR6GFP/GFP). Their transcript expression levels were quite
low (Figure 4D). We observed a tendency to the decrease accordingly with the loss of CXCR6 alleles
suggesting that IL-4 and IL-9 expression may be perturbed. However, differences were not significant
and mRNA levels were so low in quantity that correlations could not be affirmative.
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Figure 4. Maintenance of type 2 secretion by ILC2 in CXCR6 deficient mice after papain induction.
(A) Flow cytometry analysis of CD45+ Lin− (CD3, CD5, CD19, TCRβ, TCRγδ, Gr1, Ter119, CD8α
and F4/80) NKp46− Sca1+ ICOS+ lung cells from Rag−/− CXCR6+/+, Rag−/− CXCR6+/GFP and Rag−/−
CXCR6GFP/GFP mice. Different subsets are disigned in function of IL-5 and IL-13. (+/+ = 5, +/GFP = 13,
GFP/GFP = 11) (B) Dosage by ELISA of IL-5 and IL-13 secretions from BAL of Rag−/− CXCR6+/+, Rag−/−
CXCR6+/GFP and Rag−/− CXCR6GFP/GFP mice. (+/+ = 5, +/GFP = 13, GFP/GFP = 11) (C) Absolute
number of eosinophils (CD45+ Lin− SiglecF+ CD11b+) from Rag−/− CXCR6+/+, Rag−/− CXCR6+/GFP
and Rag−/− CXCR6GFP/GFP mice in BAL (left graph) and lung (right graph). (+/+ = 5, +/GFP = 13,
GFP/GFP = 11) (D) 1000 ILC2 (Lin− CD45+ NK1.1− ST2+) were sorted from Rag−/− CXCR6+/+, Rag−/−
CXCR6+/GFP and Rag−/− CXCR6GFP/GFP mice. After mRNA extraction, gene study was performed
by real time RT-PCR. Relative expression of IL-4 and IL-9 genes (expression compared to Hprt gene),
(+/+ = 6, +/GFP = 6, GFP/GFP = 6).
2.5. CXCR6 Deficiency Also Alters the Number and Functions of Type 1 Innate Lymphoid Cells
We decided to analyze pulmonary NK/ILC1 after papain-induced inflammation since some lung
NK/ILC1 can express CXCR6. Using CXCR6-sufficient and -deficient animals, we determined the
impact of CXCR6 on the repartition of NK/ILC1 at steady-state and after lung inflammation (Figure 5A).
In steady-state conditions, KLRG1 was expressed by a very small amount of NK/ILC1 representing
between 1–2% of the population and no significant difference was observed (Figure 5A, left panels).
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However, after papain-induced inflammation, recruited NK/ILC1 were largely CXCR6+KLRG1+ cells
and it was evident that KLRG1 expression was nearly absent from CXCR6-deficient NK/ILC1 of
the lungs (Figure 5A, left panels). Moreover, papain administration also increased the frequency of
CXCR6+ cells in the KLRG1− subset (Figure 5A, left panels). This significant increase was not observed
in CXCR6GFP/GFP-deficient lungs demonstrating the important role of CXCR6 in the recruitment of
these new inflammatory subsets (Figure 5A, left panels). By separating NK/ILC1 based on their
CD127 expression, we determined that the CXCR6 deficiency preferentially prevented ILC1-like
accumulation in lungs after induction of airway inflammation (Figure 5A, right panels). Indeed, even
by diluting CXCR6+ ILC1 with CXCR6− ILC1, the decrease in total ILC1 numbers after inflammation
was still significant (Figure 5B). On the contrary, NK cells were not significantly different in numbers,
mainly because CXCR6+ NK cells were too few and their decrease was diffused among the CXCR6
independent population. CXCR6-deficient mice in a WT background were also analyzed for the
repartition of ILC1/NK populations after papain stimulation (Figure S4). Globally, the absence of
CXCR6 in mice with T and B cells had similar issues with a stronger decrease of lung ILC1 numbers.
It is interesting to observe that in presence of T and B cells, NK cells were also importantly decreased
after inflammation while their frequency of CXCR6+ cells were unchanged at a low 8% rate. It appears
that the recruitment of NK cells in case of lung inflammation might be indirectly dependent on CXCR6
expression by lymphocytes.
Finally, we compared IFNγ secretive abilities between CXCR6-deficient and -sufficient mice and
observed that IFNγ secreting ILC1 were significantly decreased (Figure 5C). In case of low IFNγ
secretion levels, secreting ILC1 only tend to decrease. The dilution of CXCR6+ NK cells was again too
strong to reveal a significant decrease of IFNγ secretion but a tendency to the decrease was emerging
(Figure 5C).
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Figure 5. CXCR6 deficiency alters ILC1 numbers and functions after papain induction. (A) Flow
cytometry analyses of ILC1/NK (Lin−:CD3, CD5, CD19, TCRβ, TCRγδ, Gr1, Ter119, CD8α, F4/80;
CD45+ NK1.1+ NKp46+) lung cells from Rag−/− CXCR6+/GFP and Rag−/− CXCR6GFP/GFP mice. Different
subsets are distinguished by the expression of KLRG1 and CXCR6 (left panel of graphs) or CD127 and
CXCR6 (right panel of graphs). (B) Absolute numbers of NK cells (Lin− CD45+ NKp46+ EOMES+)
and ILC1 (lin− CD45+ NKp46+ CD127+) from Rag−/− CXCR6+/+, Rag−/− CXCR6+/GFP and Rag−/−
CXCR6GFP/GFP mice. (C) Absolute number of IFNγmed and IFNγhigh NK cells (Lin− CD45+ NKp46+
CD127−) (2 left graphs) and ILC1 (lin− CD45+ NKp46+ CD127−) (2 right graphs) from Rag−/− CXCR6+/+,
Rag−/− CXCR6+/GFP and Rag−/− CXCR6GFP/GFP mice. (+/+=10, +/GFP=9, GFP/GFP=8) (*p < 0.05).
3. Discussion
In this study, we assessed the effect of CXCR6 deficiency on lung ILC2 and NK/ILC1 in steady state
and after papain-driven inflammation into the lungs. The effect of CXCR6 loss was analyzed using
the Rag2−/− CXCR6GFP/GFP mouse model since the GFP reporter insertion simultaneously inactivates
the corresponding Cxcr6 allele [25]. The absence of Rag2 warrants a proper ILC analysis devoid of
T-cell contamination. It was shown that tissue ILC2 and ILC3 are elevated in numbers and also secrete
increased amounts of cytokine in the Rag-deficient background [21,22]. However, CXCR6-sufficient
and -deficient mice are all on the Rag-deficient background to fairly conclude on the CXCR6 role.
Moreover, it was previously proven that activated ILC2 induce pulmonary eosinophilia independently
of the adaptive immune system [7]. In parallel, we showed that in a WT background CXCR6 is still
highly expressed by the subset of KLRG1+ iILC2 and by less than 10% of the pulmonary ILC1/NK cells.
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Hence, we concluded that the main difference found is that CXCR6 is less frequently expressed by the
resident lung KLRG1− nILC2 in case of RAG deficiency.
We observed that CXCR6 is an important chemokine that could regulate the type 1/type 2 balanced
immune response in the lungs. In homeostatic conditions, we showed that both ILC2 and NK/ILC1
pulmonary subsets are perturbed in their lung homing capacities in case of CXCR6 deficiency. Even if
ILC1 were not yet clearly defined in the lungs, we considered the CD127+ population of NKp46+NK1.1+
lung cells as being the lung resident ILC1 population. We also checked that this population was
Eomes− contrary to bona fide NK cells.
Competitive reconstitution experiments proved that the CXCR6 cell’s intrinsic role is to regulate
ILC homing to the lung. Since we have previously shown that CXCR6-deficient ILC progenitors have
a retention problem in the BM, it is equally possible that CXCR6 deficiency induces an upstream lesion
in ILC progenitor maturation that consequently limits lung ILC engraftment. Indeed, we also observed
a significant decrease of ILC1 and ILC2 in steady state lungs of CXCR6-deficient mice. Competitive
reconstitution differences were not highly different (p = 0.028) for two main reasons. The first one
is coming from the fact that ILC colonize tissue by waves and the bone marrow-derived wave only
concerns a fraction of adult tissue ILC2 [26]. The second one is due to the sparse expression of CXCR6
among lung NK/ILC1 reducing the impact of CXCR6 loss. Especially for pulmonary NK cells, only few
cells express CXCR6 and the role and effects of this molecule are largely diluted in case of depletion.
On the contrary, as CXCR6 is expressed by half of ILC1, the results were significant when ILC1 were
separated from NK cells for analyses.
There is no clear explanation of the NK/ILC1 roles in lung allergy. Lung NK cells are described as
a circulating hypofunctional subset, with more mature phenotype than in other tissues, that probably
originate from the bone marrow [20,27]. KLRG1 is an inhibitory receptor and marker of terminal
maturation acquired by mature NK cells that migrate into secondary lymphoid organs [28,29]. Mostly
associated to decreasing ability to secrete IFNγ [29], KLRG1 expression on NK cells could also reveal a
recent activation and punctual capacity to produce more IFNγ in case of inflammation [30].
In case of lung inflammation such as papain-induced airway hyperresponsiveness, the trafficking
of leukocytes is important to recruit inflammatory subsets and we demonstrated that CXCR6 deficiency
was preventing the recruitment of new incoming mature activated KLRG1+ NK cells or iILC2 [23].
While, in CXCR6-deficient lungs, KLRG1 expression is completely absent from ILC1/NK subsets,
the situation is more complex for ILC2 where new KLRG1+ ST2− iILC2 are less able to reach the lung
while nILC2 become increasingly activated and gain high expression for both ST2 and KLRG1 surface
markers. Lung KLRG1+ iILC2 were largely enriched in CXCR6-expressing cells confirming that the
iILC2 subset trafficking to the lungs is already CXCR6+. CXCR6 is important since its abrogation largely
decreases the amount of recruited iILC2 and consequently challenges the number of nILC2 by reducing
the number of cells able to differentiate into nILC2 [23,24]. Hence, it seems that circulating inflammatory
subsets are mostly CXCR6-dependent. The CXCR6+ resident subsets probably result from an in situ
differentiation of iILC2 that might receive different signals in CXCR6-deficient conditions perturbing
their activation state. Indeed, KLRG1+ ILC2 accumulation in CXCR6-deficient mice may reveal this
inability of ILC2 to be correctly localized in the lung and to further differentiate into ST2+KLRG1+ and
then ST2− nILC2.
We do not know at which stage CXCR6 is crucial; it could be crucial from an early developmental
BM stage for the maturation of ILC progenitors as already stated [15] with a direct consequence in
CXCR6+ intestinal ILC2 subsets. We analyzed the intestinal lamina propria ILC2 and showed that
more than half were CXCR6+ in steady-state conditions (Figure S5). Moreover, we showed that in
CXCR6-deficient mice, ILC2 from the mLN are significantly decreased in numbers. It appears consistent
that in CXCR6-deficient mice less iILC2 are available to reach the lung in inflammatory conditions.
Hence, CXCR6 may have different roles at different stages of their development resulting in less ILC2
in the lungs with an abnormal localization. However, iILC2 are described as strong producers of
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cytokines [23,24]. Since CXCR6+ cells are mostly pulmonary iILC2, they could be attributed to the
pool of cytokine producers. This CXCR6+ subset is reminiscent of memory ILC2 [31].
As CXCR6 may have an indirect role in the homing of ILC2 to the lungs, other chemokines have
been shown as important for the homing to the lungs. CCR4, CCR8 and CCR1 are expressed by ILC2
in steady-state conditions and are implicated in lung ILC homeostasis with a decrease of ILC2 numbers
in case of CCR4 deficiency [32,33]. After IL-33-induced inflammation, CCR8 and CCR1 are increased at
the surface of ILC2 and blockade of CCR8 could reduce both ILC2 motility and secretion suggesting an
important role for their homing to the lungs in the inflammatory context [33]. Moreover, the expression
of CCR8 has been correlated with the expression of its CCL8 ligand by inflamed epithelial cells [33].
After the induction of inflammation, lung ILC2 also express CCL1, another CCR8 ligand, and this
expression enhances their motility, proliferation and survival when interacting with the inflamed
epithelium [32].
We observed a clear decrease of IFNγ secretion activities by CXCR6-deficient lung ILC1. Despite
the absence of iILC2 in CXCR6-deficient mice, levels of type 2 cytokines were identically maintained
and the ratio of recruited eosinophils was consistently similar. It was previously shown that alarmins
expand the lung nILC2 and their IL-13 secretion. Moreover, lung nILC2 could be negatively regulated
by IFNγ [4,34]. We suspect that CXCR6-deficient nILC2 harboring high levels of ST2 and KLRG1
in the lungs were overactivated due to an absence of negative regulators. Hence, these lung nILC2
are no longer suppressed by IFNγ but are overactivated by IL-25 and IL-33 after papain induction.
In CXCR6-deficient lungs that contain less ILC2, we suggest that type 2 maintenance is explained by
the decrease of the type 1 immune response.
IL-9 was shown to be produced by iILC2 in papain-induced inflammation after a combined
IL-33/IL-2 stimulation. In our Rag models, IL-2 levels are probably more limited, explaining why IL-9
transcripts are lowly detected. Nevertheless, lung ILC2 cannot induce normal levels of IL-9 and IL-4
secretion in CXCR6 deficiency. Other models of inflammation should be tested to evaluate the clear
IL-4 and IL-9 secretive state of ILC2 in CXCR6-deficient conditions. We showed that ST2− iILC2 are
responsible for the secretion of an important amount of amphiregulin in the case of papain-induced lung
inflammation. ILC2 in response to IL-33 and in situations of tissue damage secrete the amphiregulin as
part of the type 2 cellular response [35,36]. Due to the absence of this ILC2 subset, the capacity of lung
epithelium to return to homeostasis in CXCR6-deficient mice is probably challenged.
CXCR6-deficient mice in a WT background were also analyzed for the repartition of ILC1/NK
populations after papain stimulation. Globally, the absence of CXCR6 in mice with T and B cells had
similar issues with a stronger decrease of lung ILC1 numbers. It is interesting to observe that in presence
of T and B cells, NK cells are also importantly decreased after inflammation while their frequency of
CXCR6+ cells are unchanged and maintained at a low rate (8%). It appears that the recruitment of
NK cells in case of lung inflammation might be indirectly dependent on CXCR6 expression by T or
B lymphocytes.
In conclusion, we showed here that while CXCR6 is important in the first homeostatic event of
lung homing, this chemokine is also important in case of lung induced inflammation as it could block
the recruitment of inflammatory subsets of both type 1 and type 2 immunity. We demonstrate that
CXCR6 is intrinsically related to IFNγ secretion abilities, explaining why its deficiency favors type 2
immune responses. Then, CXCR6 deficiency could be detrimental in case of asthma inflammation
where it sustains type 2 response by the decrease of restricting type 1 secretion but limits the possible
epithelial wound healing.
4. Materials and Methods
4.1. Mice and Animal Facilities
Rag2−/− CXCR6+/+, Rag2−/− CXCR6GFP/+, Rag2−/− CXCR6GFP/GFP, CXCR6GFP/+, CXCR6GFP/GFP
and CD45.1 Rag2−/− γc−/− mice were bred in the animal facilities at Pasteur Institute, Paris. Mice were
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cared for in accordance with Pasteur Institute guidelines in compliance with European animal welfare
regulations; all animal studies were approved by Pasteur Institute Safety Committee according to
the ethic charter approved by French Agriculture ministry and to the European Parliament Directive
2010/63/EU. Project 02080.02 recorded the 5/10/2016.
4.2. Inflammation of Lung
Induced allergic lung inflammation in mice was generated by papain administration. A total of
40 µg of papain (Sigma Chemical, St. Louis, MO, USA) was administered intranasally to anesthetized
mice by two injections (J0 and J4), 20 µg for each injection in 50 µL PBS 1X. ILC2s and eosinophils were
analyzed 5 days after the first administration.
Anesthesia was a mix of Ketamin (Merial, Lyon, France, 100 mg/kg) and Xylazin (Bayer, Leverkusen,
Germany, 10 mg/kg).
4.3. Cell Preparation
Lungs were harvested and washed by PBS 1X injection. After being cut in small fragments, lungs
were incubated 45 min at 37 ◦C and 5% CO2 in RPMI medium (Gibco ThermoFisher, Waltham, Mass.,
USA) plus collagenase type IV (Gibco ThermoFisher, Waltham, MA, USA, 275,000 UI/mg) and DNAse
I (Roche, Basel, Switzerland, 50 µg/mL). Lungs were mechanically crushed, spun and resuspended in a
40% solution of Percoll (GEHealthcare, Nightingales, UK). After centrifugation for 20 min at 600× g,
cells were collected in cold HBSS medium (Gibco ThermoFisher, Waltham, MA, USA) plus 1% fetal
calf serum (FCS).
Small intestines were harvested and washed of their contents by PBS 1X; Peyer’s patches, if present,
were removed. After being cut open longitudinally, small intestines were cut in 1-cm fragments.
Fragments of small intestine were incubated 30 min at 37 ◦C and 5% CO2 in RPMI medium plus 20%
FCS and HEPES buffer (Sigma Chemical, St. Louis, MO, USA, 10 µM). Small intestines were vortexed
thoroughly for 4 min for removal of epithelial cells and intraepithelial lymphocytes. Remaining
fragments of small intestine were incubated 30 min at 37 ◦C and 5% CO2 in RPMI medium plus 20%
FCS, HEPES Buffer and collagenase type VIII (Sigma Chemical, St. Louis, MO, USA, 250 µg/mL) for the
isolation of LP lymphocytes. Cell suspensions were spun and resuspended in a 40% solution of Percoll.
After centrifugation for 20 min at 600× g, cells were collected in cold HBSS medium plus 1% FCS.
Blood was harvested and diluted two times in PBS 1X. Cell blood suspension was put on FICOLL
medium (2 volumes of cell suspension for 1 volume of FICOLL). After centrifugation for 20 min at
600× g, cells were located in ring between FICOLL and plasma, and were collected in cold HBSS
medium plus 1% FCS.
Mesenteric lymph nodes (mLN) were harvested and mechanically dissociated in HBSS medium
plus 1% FCS to obtain cell suspension.
All cell suspensions were spun 5 min at 450× g; pellets were resuspended in appropriate volume.
All cell suspensions were counted on Malassez cell and dead cells were excluded using Trypan Blue.
4.4. Lymphocyte Activation
Lymphocytes were activated by culture in OPTIMEM medium plus 10% FCS, β-Mercapto-ethanol
(Gibco ThermoFisher, Waltham, MA, USA, 500 µM), penicillin (Gibco ThermoFisher, Waltham, MA,
USA, 5 U/mL), streptomycin (Gibco ThermoFisher, Waltham, Mass, USA, 5 µg/mL), Monensin
(ThermoFisher, Waltham, MA, USA, 2 µM), Brefeldin A (BD Biosciences, Franklin Lakes, NJ, USA,
3 µg/mL), Phorbol 12-myristate 13-acetate (PMA) (Sigma Chemical, St. Louis, MO, USA, 0.05 µg/mL)
and Ionomicin (Sigma Chemical, St. Louis, MO, USA, 1 µg/mL). Cells were cultured for 3 h at 37 ◦C
and 5% CO2 and then harvested and stained for analysis.
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4.5. Flow Cytometry
Streptavidin was coupled to PE-Cy5. The following antibodies were either biotinylated or coupled
to fluorochromes (FITC or GFP, PerCP-Cy5.5, PE, PE-Cy7, APC, APC-Cy7, BV421, BV605, BV650,
BV711, BV786): Ly76 (TER-119), Gr-1 (RB6-8C5), CD11c (HL3), CD3ε (145-2C11), CD19 (6D5), CD8α
(53-6.7), CD5 (53-7.3), TCRβ (H57-597), TCRγδ (GL-3), NK1.1 (PK136), NKp46 (29A1.4), IL-7Rβ (A7R34),
Sca-1 (D7), ST2 (DIH9), CD4 (GK1.5), CD45.2 (104), Thy1.2 (53-2.1), ICOS (C398.4A), Gata3 (L50-823),
F4/80 (BM8), Siglec-F (E50-2440), IFNγ (XMG1.2), IL-5 (TRFK5) and IL-13 (eBio13A). Lineage cocktails
were as follows: CD3ε, CD5, CD8, CD19, F4/80, TCRβ, TCRγδ and Ter119. All antibodies were
purchased from BD Biosciences (Franklin Lakes, NJ, USA), eBiosciences (Thermo Fisher, Waltham, MA,
USA) or Biolegend (San Diego, CA, USA).
After antibody staining, cells were washed. Cells were stained intra-cellularly using Foxp3
Permeabilzation/Fixation Kit according to manufacturer’s notice (eBiosciences, ThermoFisher, Waltham,
MA, USA). Cells were washed prior to cell acquisition. LSR Fortessa (BD Biosciences, Franklin Lakes,
NJ, USA) was used for flow cytometry acquisition, with Diva6 software (BD Biosciences, Franklin
Lakes, NJ, USA), and analyzed with FlowJo 10 software (FlowJo LLC, Ashland, OR, USA). For visual
purposes, only 8000 events maximum are shown in each FACS dot plot. Cells were purified with a
FACSAria III sorter (BD Biosciences, Franklin Lakes, NJ, USA). Cells were recovered in PBS for cell
injection, or OPTIMEM (Gibco, Thermo Fisher, Waltham, MA, USA) plus 10% FCS for cell culture.
4.6. In Vivo Reconstitution
CD45.1+ Rag2−/− γc−/− mice were sub-lethally irradiated (400 rad) at least 4 h prior to cell injection.
A total of 4000 CD45.1+ LSK (Lin− IL-7Rα− c-Kit+ Sca1+) cells from wild type adult bone morrow and
4000 CD45.2+ CXCR6+ LSK cells from CXCR6+/GFP or CXCR6GFP/GFP adult bone morrow were sorted
and then mixed at a 1:1 ratio for injection. Retro-orbital i.v. injections were performed, and mice were
analyzed 8 weeks after injection.
4.7. RT-qPCR Analysis
ILC2 were sorted in Buffer RLT (Qiagen, Venlo, Netherlands) containing 2-mercaptoethanol
(Sigma Chemical, St. Louis, MO, USA) and were frozen at −80 ◦C. RNA was obtained with an RNeasy
Micro Kit (Qiagen, Venlo, Netherlands) and complementary DNA (cDNA) was obtained with the
PrimeScript RT Reagent Kit (Takara, Kyoto, Japan). A 7300 Real-Time PCR System (Applied Biosystems,
ThermoFisher, Waltham, MA, USA) and TaqMan technology (Applied Biosystems, ThermoFisher,
Waltham, MA, USA) or SYBR Green Technology (Qiagen, Venlo, Netherlands) were used for qRT-PCR
analysis. The following primers were from ThermoFisher (Waltham, MA, USA): IL-4 (Mm00445259_m1)
and IL-9 (Mm00434305_m1).
4.8. Exsanguination Experiment
Anti-CD45 antibody coupled with a fluorochrome was administered to mice by i.v. injection.
After 2 min, the mice were sacrificed, organs were treated normally, and cells were labeled as
previously described.
4.9. Statistical Analysis
All data were submitted to Student’s unpaired bilateral t-test. Data were deemed significantly
different when * p < 0.05, ** p < 0.01, or *** p < 0.005.
In all figures, histograms are represented as means including SD based on number of replicates
indicated in figure legend.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/20/21/
5493/s1.
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